Publications Durham NC | HIV Publications & Articles

Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease

Nelson CS, Baraniak I, Lilleri D, Reeves MB, Griffiths PD, Permar SR.. J Infect Dis. 2020 Mar 5;221(Supplement_1):S45-S59. doi:10.1093/infdis/jiz428.

Safety and Immune Responses After a 12-month Booster in Healthy HIV-uninfected Adults in HVTN 100 in South Africa: A Randomized Double-Blind Placebo-Controlled Trial of ALVAC-HIV (vCP2438) and Bivalent Subtype C gp120/MF59 Vaccines

Laher F, Moodie Z, Cohen KW, Grunenberg N, Bekker LG, Allen M, Frahm N, Yates NL, Morris L, Malahleha M, Mngadi K, Daniels B, Innes C, Saunders K, Grant S, Yu C, Gilbert PB, Phogat S, DiazGranados CA, Koutsoukos M, Van Der Meeren O, Bentley C, Mkhize NN, Pensiero MN, Mehra VL, Kublin JG, Corey L, Montefiori DC, Gray GE, McElrath MJ, Tomaras GD. Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines. PLoS Med. 2020 Feb 24;17(2):e1003038. doi: 10.1371/journal.pmed.1003038. PMID: 32092060.

Addressing the Physician-Scientist Pipeline: Strategies to Integrate Research Into Clinical Training Programs

Permar SR, Ward RA, Barrett KJ, Freel SA, Gbadegesin RA, Kontos CD, Hu PJ, Hartmann KE, Williams CS, Vyas JM. Addressing the physician-scientist pipeline: strategies to integrate research into clinical training programs. J Clin Invest. 2020 Feb 10:136181. doi: 10.1172/JCI136181. Epub ahead of print. PMID: 32039914.

HCMV Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses With Greater Durability and Breadth Than MF59-adjuvanted gB Protein Immunization

Nelson CS, Jenks JA, Pardi N, Goodwin M, Roark H, Edwards W, McLellan JS, Pollara J, Weissman D, Permar SR. J Virol. 2020 Feb 12:JVI.00186-20. doi:10.1128/JVI.00186-20. Epub ahead of print. PMID: 32051265.

Intrahost Cytomegalovirus Population Genetics Following Antibody Pretreatment in a Monkey Model of Congenital Transmission

Vera Cruz D, Nelson CS, Tran D, Barry PA, Kaur A, Koelle K, Permar SR. PLoS Pathog. 2020 Feb 14;16(2):e1007968. doi: 10.1371/journal.ppat.1007968. PMID: 32059027.

Breast Milk and Saliva Lactoferrin Levels and Postnatal Cytomegalovirus Infection

Weimer KED, Roark H, Fisher K, Cotten CM, Kaufman DA, Bidegain M, Permar SR. Am J Perinatol. 2020 Feb 18:10.1055/s-0040-1701609. doi: 10.1055/s-0040-1701609. Epub ahead of print. PMID: 32069486.

Innovations in HIV-1 Vaccine Design

Jones LD, Moody MA, Thompson AB. Clin Ther. 2020 Feb 5:S0149-2918(20)30044-8. doi: 10.1016/j.clinthera.2020.01.009. Epub ahead of print. PMID: 32035643.

Immunological Mechanisms of Inducing HIV Immunity in Infants

Fouda GG, De Paris K, Levy O, Marchant A, Gray G, Permar S, Marovich M, Singh. Vaccine. 2020 Jan 16;38(3):411-415. doi: 10.1016/j.vaccine.2019.11.011. Epub 2019 Nov 21. PMID: 31761501; PMCID: PMC6955149.

Shortening HIV vaccine regimens to achieve high coverage

Blasi M, Fouda GG. [published online ahead of print, 2020 Feb 17]. Lancet HIV. 2020;S2352-3018(20)30039-4. doi:10.1016/S2352-3018(20)30039-4

Immune checkpoint modulation enhances HIV-1 antibody induction. Nat Commun.

Bradley T, Kuraoka M, Yeh CH, Tian M, Chen H, Cain DW, Chen X, Cheng C, Ellebedy AH, Parks R, Barr M, Sutherland LL, Scearce RM, Bowman CM, Bouton-Verville H, Santra S, Wiehe K, Lewis MG, Ogbe A, Borrow P, Montefiori D, Bonsignori M, Anthony Moody M, Verkoczy L, Saunders KO, Ahmed R, Mascola JR, Kelsoe G, Alt FW, Haynes BF. Nat Commun. 2020 Feb 19;11(1):948. doi:10.1038/s41467-020-14670-w. PMID: 32075963.

Publications